yes this stock is ridiculously priced i don't understand how people have missed it. look at the last 3 quarters of revenue growth: march was $1.04m, June was $2.78m, sept was $3.95m. granted there was an acquisition in may for basis2 which has helped revenue increase although that was paid for in cash and they are definitely growing the core business revenue something big.
ceo just stated they are on track to turn maiden profit in fy 18, wont be surprised if its this quarter
just checked out the sell side and looks like a few people have woken up this stock's potential
see you at 50c
- Forums
- ASX - By Stock
- NOV
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-3
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $13.81M |
Open | High | Low | Value | Volume |
3.7¢ | 4.1¢ | 3.4¢ | $187.9K | 4.949M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 127555 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27555 | 0.034 |
4 | 217935 | 0.033 |
8 | 525120 | 0.032 |
8 | 506731 | 0.031 |
10 | 1286467 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 150000 | 1 |
0.036 | 1300000 | 1 |
0.038 | 100000 | 1 |
0.039 | 400000 | 2 |
0.040 | 2342775 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online